COMPANY
Novitium Pharma
FDA-approved therapeutic company
Timeline
- FDA FDA Original approval: INZIRQO (hydrochlorothiazide) — NDA219141, Jan 28, 2025. Applicant at approval: Novitium Pharma LLC. source ↗
FDA records (last 2 years)
- FDA Original approval: INZIRQO (hydrochlorothiazide) — NDA219141, Jan 28, 2025. Applicant at approval: Novitium Pharma LLC. source ↗